[1] Rubello D, Piotto A, Pagetta C, et al. (99m)Tc-MIBI radio-guided surgery for recurrent thyroid carcinoma:technical-and preliminary clinical results. Eur J Nucl Med Mol Imaging, 2002, 29(9):1201-1205.
[2] Forssel-Aronsson, Nilsson O, Benjegard SA, et al.111In-DTPA-D-Phel-octreotide binding and somatostatin receptor subtype in thyroid tumour. J Nucl Med, 2000, 41(4):636-642.
[3] Chang CT, Liu FY, Tsai JJ, et al. The clinical usefulness of dual phase 201TI thyroid scan for false-negative fine-needle aspiration cytological diagnoses in non-functioning cold thyroid nodules.Anticancer Res, 2003, 23(3C):2965-2967.
[4] Mitchell G, Pratt BE, Vini L, et al. False positive 131I whole body scans in thyroid cancer. Br J Radiol, 2000, 73(870):627-635.
[5] Xie BK, Guan YB, Yuan XP, et al. Relationship between computed tomography(CT)manifestations and pathology in thyroid carcinoma. Ai Zheng, 2003, 22(2):192-197.
[6] Schillaci O. Functional-anatomical image fusion in neuroendocrine tumours. Cancer Biother Radiopharm, 2004, 19(1):129-134.
[7] Fujita A, Hyodog H, Kawamura Y, et al. Use of fusion images of I-131 metaiodobenzylguanidine, SPECT and magnetic resonance studies to identify a malignant phecchromocytoma. Clin Nucl Med,2000, 25(6):440-442.
[8] Krausz Y, Keidar Z, Kogan I, et al. SPECT/CT hybrid imaging with 111In-pentetreotide in assessment of neuroendocrine tumours. Clin Endocrinol (Oxf), 2003, 59(5):565-573.
[9] Even-Sapir E, Keidar Z, Sachs J, et al. The new technology of combined transmission and emission tomography in evaluation of endocrine neoplasms. J Nucl Med, 2001, 42(7):998-1004.
[10] Tharp K, Israel O, Hausmann J, et al. Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma. Eur J Nucl Med Mol Imaging,2004, 31(10):1435-1442.
[11] Kostakoglu L, Goldsmith SJ. 18F-FDG evaluation of the response to therapy for lymphoma and for breast,lung, and colorectal carcinoma. J Nucl Med, 2003, 44(2):224-239.
[12] Chapman JD, Bradley JD, Eary JF, et al. Molecular (functional)imaging for radiotherapy applications:An RTOG symposium. Int J Radiat Oncol Biol Phys, 2003, 55(2):294-301.
[13] Ruf J, Lelunkuhl L, Bertram H, et al. Impact of SPECT and integrated low-dose CT after radioiodine therapy on the management of patients with thyroid carcinoma. Nucl Med Commun, 2004, 25(12):1177-1182.
[14] LUO Quan-yong, CHEN Li-bo, YU Yong-li, et al. Clinical analysis of false positive131I therapeutic scan in differentiated thyroid cancer. Chin J Med Imaging Technol. 2004, 20(12):1930-1932.
[15] Akoglu E, Dutipek M, Bekis R, et al. Assessment of cervical lymph node metastasis with different imaging methods in patients with head and neck squamous cell carcinoma. J Otolaryngol, 2005, 34(6):384-394.
[16] Yamamoto Y, Nishiyama Y, Monden T, et al. Clinical usefulness of fusion of 131I SPECT and CT images in patients with differentiated thyroid carcinoma. J Nucl Med, 2003, 44(12):1905-1910.
[17] Schillaci O. Hybrid SPECT/CT:a new era for SPECT imaging?. Eur J Nucl Med Mol Imaging, 2005, 32(5):521-524.